This is the result of
10 years of know-how.
이벤트 및 해당 메뉴의 카테고리 관련 대표 카피문구 및
마이크로 사이트 이동 채널의 영역으로 사용 가능합니다.
Pharos Vaccine has been proactively conducting joint researches with professional institutions and experts for developing bio-pharmaceuticals efficiently and effectively.
Validity evaluation of the Inhibition of RA progress and treatment of genetically modified T-cells in the mouse model for rheumatoid arthritis
Medical Product Evaluation Support Service
(Osong High-Tech Medical Industry Promotion Foundation)
2019.10 ~ 2020.04
A Study on the optimization of immunosuppressive factor-Resistance CAR T-cell therapy
Source Technology Development Project
(Ministry of Science and ICT)
2017.06 ~ 2020.06
Development of CD19-CAR T cellular-genetic Therapy and construction of GMP manufacturing facility
Innovative New Drug Research and Development Consulting Program
(Ministry of Health and Welfare)
Validity evaluation of the Inhibition of RA progress of tolerogenic dendritic cells in the mouse model for rheumatoid arthritis
2017.05 ~ 2017.08
Development of tissue-regenerating dendritic cell therapy as a cell therapy for acute myocardial infarction
Leading Convergence Research Group on Immunological Diseases
(Korea Health Industry Promotion Agency)
2014.10 ~ 2019.11